Northern Star Resources is under Algo Engine buy conditions. The expected rally from sub $10 is now underway.
4/5 We again highlight Northern Star as our preferred gold play.
7/5
17/5 Buy NST within the $10.50 to $11.00 support range.
Our Algo Engine flagged a recent buy signal in TWE:ASX at or near $10.00. Traders may consider a stop-loss below the $9.93 pivot low.
17/5 TWE is now trading $11.08 and the share price remains above the 10-day average.
Lendlease has switched to Algo Engine buy conditions and has now been added to our ASX 100 model portfolio.
Watch for renewed buying interest above the recent $11.50 support level.
Option traders: We’re buying the $12 Dec call options at $0.85.
CIM:ASX is likely to see improved earnings in FY22 and we expect to soon see a recovery in the share price.
CIMIC is a high risk counter trend investment with the prospect of a multi-year recovery, once earnings hit an inflection point.
24/4 CIMIC breaks above the 10-day average after forming a new trend low mid-week at $16.86.
10/5 Dec 21 $20 call options are now trading at $1.10.
14/5 CIMIC is now trading $19.84 and the Dec $20 calls have jumped from $1.10 to $1.50.
17/5 CIMIC is now trading $20.56 and the Dec $20 calls have jumped from $1.10 to $1.75.
ASX:IZZ is under Algo Engine buy conditions. We expect buying interest to increase within the $55 – $60 price range.
Traders may wait for the third factor to align, an upturn in the momentum indicators. Watch for the stochastic to move higher or the price action on the main chart to cross above the 10-day average.
CURE:AXW is under Algo Engine buy conditions and the current pullback provides another buying opportunity.
17/5 CURE is now experiencing an increase in buying interest and the stochastic short-term momentum indicator has turned higher.
ETFS S&P Biotech ETF (ASX Code: CURE) offers investors exposure to U.S. biotechnology companies. These companies are engaged in research, development, manufacturing and/or marketing of products based on genetic analysis and genetic engineering.
.
For our Members, please find below the list of our latest Model Portfolio changes.
Carsales.Com is under Algo Engine sell conditions and is not currently in our portfolio.
We highlight the recent announcement where Carsales will acquire a 49% stake in a US marketplace business for A$797m. The acquisition is mainly funded with a A$600m equity raising.
We expect 5 – 10% revenue growth and EBIT increasing from $230m to $270m in FY22. This supports a forward dividend yield of 2.6%.
Xero is under Algo Engine buy conditions and is a current holding in our ASX 100 model.
The high EBITDA margins reported in the 1H appear to be a one-off due to lower constrained operating costs during COVID. The sell-off in XRO share price following the FY21 result is reflective of the market recalibrating the growth rate.
A normalization of operating margins will likely be more in the 16 – 18% range rather than the near 30% reported in the first half results.
We continue to see solid revenue growth and are comfortable buying XRO on or near our support range.
Altium is under Algo Engine buy conditions. The share price is oversold and likely to rally from the current level.
A more conservative entry strategy will be to wait for the stochastic to turn higher or the price action to cross up through the 10-day average.
Level 29 Chifley Tower
2 Chifley Square
Sydney, NSW 2000
1300 614 002
Investor Signals Pty Ltd
ABN 44 143 555 453
Or start a free thirty day trial for our full service, which includes our ASX Research.